Ignite Creation Date:
2024-05-06 @ 10:31 AM
Last Modification Date:
2024-10-26 @ 12:31 PM
Study NCT ID:
NCT03282643
Status:
COMPLETED
Last Update Posted:
2019-04-16
First Post:
2017-09-12
Brief Title:
Rivaroxaban Versus Low-molecular-weight Heparin for Preventing Thrombosis in Cancer Patients
Sponsor:
Capital Medical University
Organization:
Capital Medical University
Organization Data
Organization:
Capital Medical University
Class:
OTHER
Study ID:
Rivaroxaban vs heparin
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Capital Medical University
Lead Sponsor Class:
OTHER
Responsible Party:
Jun Ren MD PhD
Responsible Party Title:
Dean Director
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Capital Medical University
Old Name:
None
Old Organization:
None